Skip to content

Docs (opens in a new tab)Pricing Ideas Benchmark

Sign in Sign up

A

AKTS

Aktis Oncology, Inc.

NASDAQHealthcareBiotechnologyUS

NASDAQ · Healthcare · Biotechnology · US

$15.20

+1.74%

FinancialsValuationProfitabilityGrowthCapitalMomentum

EarningsOwnershipNewsIdeas

Idea

No published Drillr research on AKTS yet.

Ask Drillr about AKTS Browse research →

Data parsed from primary filings: SEC EDGAR · EDINET · HKEX · CNINFO · DART. Prices delayed 15 minutes.

Workspace|Docs (opens in a new tab)|Pricing|Research|Methodology|Privacy|Disclaimer|Contact|© 2026 LIL GREBE INC.